Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | What impact will biosimilars have on clinical life?

Biosimilars show significant promise in the treatment of cancer. Diana Lüftner, from the Humboldt University, Berlin, Germany talks to us about the impact that these agents will have on clinical life, and explains the process by which clinicians will assess and proceed with their use. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) held in Madrid, Spain.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.